12/29/2021Top Ten Chinese Biopharma In-licensing Deals in 2021

12/28/2021SMEI Forecasts Outlook of Chinese Pharma in 2022

12/27/2021NMPA Announces Rx Switch of OTC Dextromethorphan Hydrobromide Oral Sin...

12/27/2021ITM and Grand Pharma Enter Licensing Deal for Targeted Radiopharmaceut...

12/27/2021Kintor Reports Unsatisfactory Interim Analysis on COVID-19 Pill Trial

12/27/2021China's 2021 Negative Lists Widen Market Access for Foreign Investment...

12/24/2021Cosunter Pharma Partners with WuXi AppTec to Co-develop New Covid Dru...

12/23/2021Luye Grants Genscience Chinese Commercialization Rights of Rivastigmin...

12/23/2021TOT Enters Co-promotion Deal with Jiangxi Jimin Kexin for Its Bevaciz...

12/23/2021Sanofi Secures Additional Indication for Multaq (Dronedarone) in China

12/23/2021Pfizer Gains Chinese Approval of ADC Drug Besponsa

12/21/2021CDE Seeks Comments on Draft Chinese Translation of ICH Guideline ICH M...

12/21/2021CStone announced New Drug Approval of Cejemly® (Sugemalimab) in China

12/21/2021Pfizer Wins Chinese BLA Approval of Inotuzumab Ozogamicin for BCP-ALL

12/20/2021NHSA Issues the List of DRG/DIP Reform Demo Trial Sites

12/20/2021NHC Issues the Guidelines for Building and Management of Pharmacy Intr...

12/20/2021Novartis and BeiGene Expands Collaboration to BeiGene's TIGIT Inhibito...

12/20/2021MOF: China To Lower Import Tariffs on 954 Products in 2022

12/20/2021Novartis Granted Chinese Approval of Its Anti-CD20 Antibody Ofatumumab...

12/20/2021Xpovio Combo Conditionally Approved in China for Repeatedly Treated rr...

12/20/2021Cytokinetics and Ji Xing Expand Collaboration for Omecamtiv Mecarbil i...

12/17/2021CBMG Cleared of U.S. IND of Bi-Specific CAR-T Cell Therapy C-CAR039...

12/17/2021BioMarin and Skyline Therapeutics in Deal to Co-develop Novel Gene The...

12/17/2021IQVIA: Chinese Retail Pharmacy Sales Up Only 0.3% in Q3/2021

12/17/2021Review of Retail Pharmacy Sales of VBP Prevailing and Failure Drug Pro...

12/17/2021Recent Executive Moves

12/16/2021US Sanctions Chinese Painkiller Makers Amid Addiction Epidemic, As Sen...

12/16/2021Zai Lab's NUZYRA Approved in China as a Class 1 New Drug for CABP and ...

12/16/2021US Sanctions Chinese Tech Firms/Institutes for Weaponizing Biotech, Sp...

12/15/2021China Biopharma, Tech Stocks Fall on Reports of Expanded U.S. Sanction...

Page:85/367 Total number of articles:10996: [First][<<] [83] [84] [85] [86] [87] [>>] [End]